AstraZeneca drug cocktail succeeds in late-stage study to treat COVID-19
The drug reduces the risk of developing severe COVID-19 or death by 50 pct in patients who had been symptomatic for seven days or less.
Mon Oct 11 2021
AstraZeneca says prospect of COVID-19 drug success underscores value of vaccine ops
Antibody drug AZD7442 was shown to prevent COVID-19 in a trial.
Fri Aug 20 2021
Program antibodi COVID-19 AstraZeneca dijangka diperoleh pertengahan 2021
Program antibodi COVID-19 yang dibangunkan AstraZeneca dijangka akan dapat diperoleh pada pertengahan tahun hadapan.
Thu Dec 03 2020